Takeda Pharmaceutical Company Limited (TYO:4502)
Japan flag Japan · Delayed Price · Currency is JPY
5,586.00
-60.00 (-1.06%)
Apr 17, 2026, 3:30 PM JST

TYO:4502 Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
8,824,8356,749,6756,564,3786,762,2045,423,4546,229,971
Market Cap Growth
26.95%2.82%-2.93%24.68%-12.95%20.89%
Enterprise Value
13,593,01011,687,79511,482,98210,868,0289,054,48110,862,765
Last Close Price
5586.004239.703842.613833.082945.783193.69
PE Ratio
79.2762.5445.5721.3323.5716.57
Forward PE
37.8632.4131.4621.6114.1218.44
PS Ratio
1.981.471.541.681.521.95
PB Ratio
1.150.970.901.060.951.20
P/FCF Ratio
8.737.8812.148.085.426.92
P/OCF Ratio
7.426.399.166.924.836.16
PEG Ratio
2.094.5319.262.83-0.33
EV/Sales Ratio
3.042.552.692.702.543.40
EV/EBITDA Ratio
10.289.4810.048.467.6511.04
EV/EBIT Ratio
22.6320.7622.9917.5415.0925.62
EV/FCF Ratio
13.4513.6521.2312.999.0612.07
Debt / Equity Ratio
0.710.730.750.770.850.98
Debt / EBITDA Ratio
4.093.964.573.794.075.16
Debt / FCF Ratio
5.375.9410.105.814.815.64
Net Debt / Equity Ratio
0.620.680.690.680.700.79
Net Debt / EBITDA Ratio
3.743.814.383.373.354.17
Net Debt / FCF Ratio
4.725.499.255.173.964.56
Asset Turnover
0.290.310.290.300.270.25
Inventory Turnover
1.161.301.301.361.401.34
Quick Ratio
0.540.440.500.490.731.00
Current Ratio
1.191.011.110.971.211.53
Return on Equity (ROE)
1.50%1.52%2.12%5.27%4.24%7.60%
Return on Assets (ROA)
2.47%2.40%2.15%2.85%2.88%2.06%
Return on Invested Capital (ROIC)
2.76%2.91%4.35%5.15%4.82%4.50%
Return on Capital Employed (ROCE)
4.70%4.80%3.90%5.40%5.40%3.80%
Earnings Yield
1.28%1.60%2.20%4.69%4.24%6.04%
FCF Yield
11.45%12.69%8.24%12.37%18.44%14.44%
Dividend Yield
3.58%4.62%4.89%4.70%6.11%5.64%
Payout Ratio
277.04%280.28%199.34%88.14%123.30%75.36%
Buyback Yield / Dilution
-0.25%-1.58%-0.67%0.46%-0.23%-0.47%
Total Shareholder Return
3.33%3.04%4.23%5.16%5.88%5.17%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.